pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 5·1 min read
save

Healthcare organizations are increasingly building their own AI tools

Big healthcare organizations are increasingly building their own AI tools, rather than shelling out for tools made by health tech startups that may eventually become free. It’s not uncommon to find that creating tools internally ...

May 5, 2026·read at Endpoints ↗

Panelists discuss whether healthcare companies should buy or build their own AI at the Digital Healthcare Innovation Summit in Boston in April 2026. (Ngai Yeung for Endpoints News) May 5, 2026 09:12 AM EDT Health Tech Health­care or­ga­ni­za­tions are in­creas­ing­ly build­ing their own AI tools Ngai Yeung Health Tech Reporter Big health­care or­ga­ni­za­tions are in­creas­ing­ly build­ing their own AI tools, rather than shelling out for tools made by health tech star­tups that may even­tu­al­ly be­come … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
110 words · retrieved May 5
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 6h agoA mix of former Republican lawmakers and Trump admin leaders are in the race to lead PhRMAEndpoints
  • 6h agoThree deaths in China shake trust in its speedy clinical trial systemEndpoints
  • 6h agoFDA rejects Osteal combo therapy to treat joint-implant infectionsEndpoints
  • 9h agoUsing gray-market versions of Lilly’s triple-G leads to relatively poor weight loss, study findsEndpoints
  • 9h agoTry first, evaluate later: How the FDA is approaching digital health devicesEndpoints